Directory › Piramal Pharma Solutions

Piramal Pharma Solutions — Morpeth

Morpeth, United Kingdom · CDMO

This is a record of what regulators published, not a rating.

Site facts

Company
Piramal Pharma Solutions
Name(s) in FDA data
Piramal Healthcare UK Limited
FEI number(s)
3002808116 (present in FDA Data Dashboard records for this name and city)
Location (as in FDA data)
Morpeth, United Kingdom
Records matched
6 FDA inspections
Most recent FDA inspection in dataset
18 Jun 2021 — VAI

Capabilities (from the company's website)

  • API / drug substance (chemical)
    …(NCL) Driving Distance: 10 miles ( 20 min) Development & Manufacturing of Oral Solids and APIs Our Morpeth, UK facility is a USFDA and MHRA inspected, fully integrated site which offer…
  • Oral solid dose
    …ational Airport (NCL) Driving Distance: 10 miles ( 20 min) Development & Manufacturing of Oral Solids and APIs Our Morpeth, UK facility is a USFDA and MHRA inspected, fully integrated site w…
  • Clinical trial supply & packaging
    …offers Active Pharmaceutical Ingredients (APIs) and oral solid drug product development, clinical supply, commercial manufacturing and packaging services to both innovators and generic pharmace…
  • Formulation & process development
    …UR VIRTUAL TOUR chevron_right VIDEO TOUR chevron_right QUICK FACT SHEET Featured Services Formulation Development and Manufacturing Our Morpeth facility offers formulation development and commercial manu…

Taken from the company's web page for this site. Source: https://www.piramalpharmasolutions.com/facilities/api-development-services-morpeth, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.

Regulatory timeline

Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.

  1. 18 Jun 2021
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002808116, inspection ID 1161558)

  2. 21 Sep 2018
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002808116, inspection ID 1099137)

  3. 13 Jan 2017
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002808116, inspection ID 1018945)

  4. 17 Oct 2014
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002808116, inspection ID 901982)

  5. 20 Nov 2012
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002808116, inspection ID 815084)

  6. 09 Apr 2009
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002808116, inspection ID 584379)

This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.